The New Zealand Drug Foundation welcomes the introduction of the Psychoactive Substances Bill, New Zealand Drug Foundation Executive Director Ross Bell said today.
“The bill is a comprehensive and thoughtful response to what is proving to be one of the biggest challenges to drug policy makers around the world,” Mr Bell said.
“As we have seen over the past few years, these substances are causing harm in our communities and this bill will allow the Government to regulate the current Wild West scenario.
“It is right that New Zealand is at the front of the pack on new laws around emerging synthetic drugs, given that New Zealand was their birthplace."
A new report shows New Zealand’s failure to adequately diagnose and treat ADHD is likely leading to significant drug harm, including from alcohol and nicotine.
Our latest report pulls together international evidence and local experiences of how neurodivergence impacts drug use
‘Microdosing’ psychedelics involves taking small, repeated doses of a psychedelic drug. Researcher Robin Murphy talks us through the latest Auckland University microdosing study.